Scientists in Austin are developing a one-of-one therapy for baby Everett Blomstrom, who has an ultra-rare genetic disease affecting fewer than 50 people worldwide.
The experimental treatment could be ready in two years and represents a breakthrough in personalized medicine for rare conditions.
Want to know more?